ストックスクリーナーアプリを入手
1.32
15.79%
0.18
プレマーケット:
1.31
-0.01
-0.76%
Proqr Therapeutics N V (PRQR) 最新ニュース
ProQR Therapeutics (NASDAQ:PRQR) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Affinity Asset Advisors LLC Makes New Investment in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat
575,000 Shares in ProQR Therapeutics (NASDAQ:PRQR) Bought by Altium Capital Management LLC - MarketBeat
ProQR Therapeutics (NASDAQ:PRQR) Given Average Rating of “Buy” by Brokerages - Defense World
Retinitis Pigmentosa Market Growth to Accelerate in Forecast - openPR.com
Retinitis Pigmentosa Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics - Barchart.com
ProQR (PRQR) Strengthens Leadership with New CFO and CMO Appointments | PRQR Stock News - GuruFocus
ProQR Strengthens Leadership with Appointments of CFO and CMO to - GuruFocus
ProQR names new CFO and CMO to bolster RNA editing platform By Investing.com - Investing.com South Africa
ProQR Therapeutics N.V. (NASDAQ:PRQR) Not Doing Enough For Some Investors As Its Shares Slump 34% - simplywall.st
ProQR names new CFO and CMO to bolster RNA editing platform - Investing.com Canada
ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth - GlobeNewswire
ProQR strengthens leadership team - The Pharma Letter
ProQR Therapeutics CFO Jurriaan Dekkers Steps Down, Dennis Hom To Succeed; Cristina Lopez Named CMO - Nasdaq
American Century Companies Inc. Invests $237,000 in ProQR Therapeutics (NASDAQ:PRQR) - Defense World
ProQR Therapeutics (NASDAQ:PRQR) Shares Acquired by Prudential Financial Inc. - Defense World
Raymond James Financial Inc. Acquires Shares of 97,928 ProQR Therapeutics (NASDAQ:PRQR) - Defense World
Virtu Financial LLC Buys New Stake in ProQR Therapeutics (NASDAQ:PRQR) - Defense World
Chardan Capital Issues Optimistic Forecast for PRQR Earnings - MarketBeat
FY2025 EPS Estimate for ProQR Therapeutics Lifted by Analyst - Defense World
28,903 Shares in ProQR Therapeutics (NASDAQ:PRQR) Acquired by PNC Financial Services Group Inc. - Defense World
Analysts Set ProQR Therapeutics (NASDAQ:PRQR) Price Target at $9.50 - MarketBeat
ProQR Therapeutics (NASDAQ:PRQR) Receives $9.50 Average Target Price from Analysts - The AM Reporter
Privium Fund Management B.V. Sells 646,755 Shares of ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat
Platinum Investment Management Ltd. Makes New $4.08 Million Investment in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat
ProQR Therapeutics (NASDAQ:PRQR) Given Consensus Rating of “Buy” by Brokerages - Defense World
ProQR Therapeutics (NASDAQ:PRQR) Earns Buy Rating from Chardan Capital - MarketBeat
HC Wainwright Forecasts Strong Price Appreciation for ProQR Therapeutics (NASDAQ:PRQR) Stock - MarketBeat
H.C. Wainwright raises ProQR stock target to $12, maintains Buy By Investing.com - Investing.com Australia
H.C. Wainwright raises ProQR stock target to $12, maintains Buy - Investing.com India
ProQR Therapeutics (NASDAQ:PRQR) Issues Quarterly Earnings Results - MarketBeat
Chardan Capital Reaffirms Buy Rating for ProQR Therapeutics (NASDAQ:PRQR) - Defense World
Raymond James maintains Strong Buy on ProQR stock, $14 target By Investing.com - Investing.com Australia
Raymond James maintains Strong Buy on ProQR stock, $14 target - Investing.com India
ProQR Therapeutics NV earnings beat, revenue fell short of estimates - Investing.com
ProQR Therapeutics NV earnings beat, revenue fell short of estimates By Investing.com - Investing.com South Africa
Proqr Therapeutics NV Files For Shelf Of Up To Up To 3.5 Million Ordinary Shares By Selling StockholderSEC Filing - Marketscreener.com
SEC Form 20-F filed by ProQR Therapeutics N.V. - Quantisnow
0.15%
4.32%
大文字化:
|
ボリューム (24 時間):